5,000 Expected to Attend Cystic Fibrosis Conference, NACFC 2019, in Nashville
The Western Hemisphere’s largest gathering of experts in cystic fibrosis gets underway later this month in Nashville, Tennessee — site of...
New Clinical Tool Predicts 1- and 2-Year Mortality in Cystic Fibrosis
Researchers in Canada have developed a novel clinical tool that uses patients’ overall health status and the risk for intermittent shock...
Lower airway infection prevalence changing in children with cystic fibrosis
The prevalence of lower airway infections with Pseudomonas aeruginosa, Staphylococcus aureus and Haemophilus influenzae among young...
AzurRx BioPharma Announces Promising Results from Trial Testing MS1819 for EPI in CF Patients
The investigational therapy MS1819 showed positive safety results in a Phase 2 clinical trial for the treatment of exocrine pancreatic...
Progress for Cystic Fibrosis [INFOGRAPHIC]
These figures were taken from the Cystic Fibrosis Foundation’s (CFF) 2017 Patient Registry Annual Data Report. The mortality rate in 2017...
![Progress for Cystic Fibrosis [INFOGRAPHIC]](https://static.wixstatic.com/media/4e4dfc_25ba3681f6844bf5b3dae109a0b15fdb~mv2.png/v1/fill/w_800,h_600,fp_0.50_0.50,q_95,enc_avif,quality_auto/4e4dfc_25ba3681f6844bf5b3dae109a0b15fdb~mv2.png)
Translate Bio Prioritizes Development of CF Therapy MRT5005, Other Lung Disease Candidates
Translate Bio is going to focus on the development of potential therapies to treat pulmonary diseases, including its lead candidate,...
Prenatal Testing for Cystic Fibrosis Influences Pregnancy Outcomes, Review Finds
Prenatal genetic testing for cystic fibrosis (CF) significantly influences how women manage their pregnancies, with positive tests linked...
Physical Activity Levels in CF Should Be Objectively Researched, Review Says
Adults with cystic fibrosis (CF) are less active than they should be, although they have comparable activity levels to people without the...
